Login / Signup

Clinical impact of circulating LAPTM4B-35 in pancreatic ductal adenocarcinoma.

Zixuan YangNorbert SenningerIsabelle FlammangQifa YeSameer A Dhayat
Published in: Journal of cancer research and clinical oncology (2019)
LAPTM4B-35 is significantly deregulated in PDAC with high diagnostic and prognostic impact as circulating tumor marker.
Keyphrases
  • circulating tumor
  • circulating tumor cells
  • cell free